Results 151 to 160 of about 92,349 (287)

Effect of Latamoxef on Platelet Function and Prothrombin Time in Partially Nephrectomized Rats

open access: gold, 1987
Kiyohisa Uchida   +4 more
openalex   +1 more source

Usefulness of preoperative peripheral blood GPC3‐positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study

open access: yesHepatology Research, EarlyView.
Peripheral blood glypican‐3 (GPC3)‐positive circulating tumor cells (CTCs) are a risk factor for microscopic portal vein invasion and a prognostic factor in Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC). Combining the number of GPC3‐positive CTCs with the up‐to‐7 criteria enables highly accurate subclassification of BCLC ...
Yosuke Namba   +15 more
wiley   +1 more source

Fully printed prothrombin time sensor for point-of-care testing. [PDF]

open access: yesBiosens Bioelectron, 2021
Williams NX   +6 more
europepmc   +1 more source

Voriconazole potentiates warfarin‐induced prothrombin time prolongation [PDF]

open access: green, 2003
Lynn Purkins   +3 more
openalex   +1 more source

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases

open access: yesHepatology Research, EarlyView.
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata   +21 more
wiley   +1 more source

Continuous Intravenous Infusion of Hepatocyte Growth Factor Promotes the Development of a Fibrolytic Phenotype in Hepatic Macrophages and Stellate Cells in a Rat Model of Bile Duct Ligation

open access: yesHepatology Research, EarlyView.
This study demonstrates that continuous intravenous infusion of hepatocyte growth factor can significantly reduce liver fibrosis in rats. This treatment promotes hepatocyte regeneration and reduces harmful inflammation, offering promising potential as a therapy for liver cirrhosis in humans. ABSTRACT Aim Liver cirrhosis is a severe condition that often
Oki Taniyama   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy